Completed PHASE2 INTERVENTIONAL 3-arm NCT01479517

Open-Label Study of Efficacy and Recommended Dose of Kovacaine Mist for Anesthetizing Maxillary Teeth

A Phase II, Single-Site, Open-Label Clinical Trial To Evaluate The Efficacy And Recommended Dosing Regimen Of Kovacaine Mist Administered Unilaterally For Anesthetizing Maxillary Teeth In Healthy Dental Patients

Sponsor: Rho, Inc.

Conditions Anesthesia

Interventions Kovacaine Mist 0.1 mL x 4 sprays Kovacaine Mist 0.2 mL x 1 spray Kovacaine Mist 0.2 mL x 2 sprays

Updated 8 times since 2017 Last updated: Nov 2, 2016 Started: Jan 31, 2012 Primary completion: Apr 30, 2012 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Anesthesia, this trial is completed. The trial is conducted by Rho, Inc. and has accumulated 8 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rho, Inc.
St. Renatus, LLC
Triligent International

Data source: St. Renatus, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Colorado Springs, United States